What is NDC 0409-7248?

0409-7248 is the product NDC for Hetastarch in Sodium Chloride (hetastarch), Hetastarch 6 g/100mL injection, solution, listed with the FDA by Hospira, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Hetastarch in Sodium Chloride (Hetastarch).

Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Hetastarch in Sodium Chloride?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Hetastarch in Sodium Chloride NDC 0409-7248

NDC codes

FDA NDC Directory

Product NDC (as listed)0409-7248Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00409-7248Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0409-7248-03	00409724803	12 CONTAINER in 1 CASE (0409-7248-03) / 500 mL in 1 CONTAINER (0409-7248-13)Marketed from Feb 28, 2005

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hetastarch in Sodium Chloride
Generic name (nonproprietary): hetastarch
Active ingredients: Hetastarch — 6 g/100mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Hospira, Inc.NDC labeler code 0409
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application BA 740193
Marketing start: Feb 28, 2005
Listing expires: Dec 31, 2027
Other FDA classes: Increased Intravascular Volume (Physiologic effect)Osmotic Activity (Mechanism)Starch (Chemical structure)
Identifiers: Product ID 0409-7248_0a543f3b-31af-41aa-8c50-a30297aaae78SPL ID 0a543f3b-31af-41aa-8c50-a30297aaae78SPL set ID d64f961a-3e1f-4b04-cf83-604474af2775RxCUI 310757UNII 875Y4127EA
Pharmacologic class: Plasma Volume Expander

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400409724803 followed by a unit qualifier and the quantity

Package 00409-7248-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 30, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

6% Hetastarch in 0.9% Sodium Chloride Injection is indicated in the treatment of hypovolemia when plasma volume expansion is desired in settings where adequate alternative treatment is unavailable. It is not a substitute for blood or plasma. The adjunctive use of 6% Hetastarch in 0.9% Sodium Chloride Injection in leukapheresis has also been shown to be safe and efficacious in improving the harvesting and increasing the yield of granulocytes by centrifugal means. • 6% Hetastarch in 0.9% Sodium Chloride Injection is a hetastarch indicated for treatment of hypovolemia when plasma volume expansion is desired in settings where adequate alternative treatment is unavailable. ( 1 ) • 6% Hetastarch i…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0409-7248

What is NDC 0409-7248?: 0409-7248 is the product NDC for Hetastarch in Sodium Chloride (hetastarch), Hetastarch 6 g/100mL injection, solution, listed with the FDA by Hospira, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Hetastarch in Sodium Chloride (Hetastarch).
What is the active ingredient?: Hetastarch.
Who is the labeler?: Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Hetastarch in Sodium Chloride?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under BA 740193

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BA 740193
Product	Strength	Form · route	Labeler	Product NDC
6% Hetastarch In 0.9% Sodium Chloride	Hetastarch 6 g/100mL	Injection, SolutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1317

Hetastarch in Sodium Chloride (Hetastarch) NDC 0409-7248